KER-047
- Generic Name
- KER-047
A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Keros Therapeutics, Inc.
- Registration Number
- NCT05927012
- Locations
- 🇮🇱
Laniado Hospital - Sanz Medical Center, Netanya, Israel
🇮🇱Hadassah University Medical Center, Jerusalem, Israel
🇮🇱Galilee Medical Center, Nahariya, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath